CAS 1233231-30-5

Formule : C20H20F3N5O2

InChI : InChI=1S/C20H20F3N5O2/c1-10(19(24)29)25-9-16-26-15-5-6-17(27-20(15)28(16)11-3-2-4-11)30-12-7-13(21)18(23)14(22)8-12/h5-8,10-11,25H,2-4,9H2,1H3,(H2,24,29)/t10-/m0/s1

Code InChI : HHXCJIMPEJSJTG-JTQLQIEISA-N

SMILES : C[C@@H](C(=O)N)NCC1=NC2=C(N1C3CCC3)N=C(C=C2)OC4=CC(=C(C(=C4)F)F)F

DSP-2230

CAS : 1233231-30-5

DSP-2230 is a selective blocker of Nav1.7/Nav1.8.

Formule : C₂₀H₂₀F₃N₅O₂

Degré de pureté : 97.14% - 99.68%

Couleur et forme : Solid

Masse moléculaire : 419.4003

Ref: TM-T15174

DSP-2230

CAS : 1233231-30-5

DSP-2230

Formule : C₂₀H₂₀F₃N₅O₂

Degré de pureté : ≥95%

Masse moléculaire : 419.4

Ref: 54-BUP04079

DSP-2230

CAS : 1233231-30-5

Ref: IN-DA01V2RW

DSP-2230

CAS : 1233231-30-5

(S)-2-(((3-Cyclobutyl-5-(3,4,5-trifluorophenoxy)-3H-imidazo[4,5-b]pyridin-2-yl)methyl)amino)propanamide

Formule : C₂₀H₂₀F₃N₅O₂

Degré de pureté : 97%

Masse moléculaire : 419.4

Ref: IN-DG01145152

DSP-2230

CAS : 1233231-30-5

DSP-2230 is a study drug that is designed to block the sodium channel. It has been shown to be safe and well tolerated in humans, with no significant side effects. DSP-2230 showed potential to reduce symptoms of neuropathic pain in human subjects and was tested for its ability to block radiation-induced damage to DNA. In addition, it inhibits the activity of ultraviolet (UV) radiation on women's skin. The mechanism of action in this case is not known, but may involve inhibiting the production of reactive oxygen species and/or blocking UV-induced increases in DNA strand breaks.

Formule : C₂₀H₂₀F₃N₅O₂

Degré de pureté : Min. 95%

Masse moléculaire : 419.4 g/mol

Ref: 3D-IZB23130